People

Mary Wozniak

web.archive.org

Mary Wozniak was publicly named by Arkuda Therapeutics as Senior Research Associate. She investigated how reduced progranulin affects FTD-GRN. Her biography identifies a behavioral-neuroscience degree from Northeastern University and industry neurodegeneration research experience. Arkuda affiliation is historical; continued employment or board membership after the2025 asset sale is unverified.